Aft, Forsyth & Company, Inc. Moderna, Inc. Transaction History
Aft, Forsyth & Company, Inc.
- $174 Million
- Q1 2024
A detailed history of Aft, Forsyth & Company, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Aft, Forsyth & Company, Inc. holds 5,158 shares of MRNA stock, worth $626,490. This represents 0.32% of its overall portfolio holdings.
Number of Shares
5,158
Previous 5,178
0.39%
Holding current value
$626,490
Previous $514,000
6.81%
% of portfolio
0.32%
Previous 0.33%
Shares
9 transactions
Others Institutions Holding MRNA
# of Institutions
1,041Shares Held
245MCall Options Held
12.1MPut Options Held
9.36M-
Baillie Gifford & CO44.7MShares$5.42 Billion3.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA39MShares$4.74 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY25.4MShares$3.08 Billion0.06% of portfolio
-
State Street Corp Boston, MA14.5MShares$1.76 Billion0.07% of portfolio
-
Flagship Pioneering Inc. Cambridge, MA9.67MShares$1.17 Billion67.87% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $47.5B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...